Novotech

The company provides biometrics data management, statistical planning and analysis, and regulatory submission and reporting for clinical trials.

Novotech’s streamlined and integrated clinical trial services are delivered by a dedicated team of professionals with deep industry and therapeutic area expertise across all phases of clinical development.

Novotech provides services for early-phase clinical trials, including Phase 1 CROs, clinical trial units, and early-phase CROs.

The company provides bioanalytical services throughout all stages of molecule development.

The page discusses how listening, useful communication, and early input can strengthen clinical trial site engagement before enrollment.

Evolution of Clinical Trials in Asia Pacific

Clinical Trial Planning in Asia: A Roadmap for Biotech Sponsors, Upcoming Webinar Ho

The page names Novotech and is dated 25 September 2026.

“John brings tremendous leadership to Novotech, and a proven track record of success.

Sydney, Australia:&nb

Novotech offers a flexible benefits framework intended to support work-life balance and professional satisfaction.

Novotech offers employees opportunities to work with cross-functional teams and advance within or across the organization.

Novotech describes a workplace culture that offers employees trust, flexibility, and autonomy.

Novotech lists open roles.

Novotech has received industry awards for clinical trial execution, scientific advisory, and workplace culture.

Novotech describes its approach as collaborative and science-driven, combining global insight with local expertise.

Novotech says its work includes advancing clinical research and supporting local communities.

Executive Leadership TeamNovotech’s leadership combines deep expertise with a strong commitment to advancing clinical research.

HEAD OFFICE Novotech (Australia) Pty Limited Level 3, 235 Pyrmont Street Sydney, AUSTRALIA

Novotech is a global full-service clinical research organization (CRO) and scientific advisory partner for biotech and small to mid-sized pharma companies.